🆕 VISIBLE data from #EADVCongress: Tremfya improved #PsA symptoms and health-related QOL measures for people with skin of color.
📈Joseph Merola, MD, of UTSW Dermatology breaks down the latest data.
@gohealio.bsky.social
www.healio.com/news/dermato...
From new approaches in alopecia areata (AA) assessment to emerging agents for hidradenitis suppurativa (HS), catch up on the insights you might have missed at this year’s #EADVCongress with our NEW highlights #MedSky #DermSky #EADV2025
ow.ly/bbzF50X7RSf
What are the key takeaways in #CSU management from #EADVCongress? Catch-up on the updates you need to know, from clinical outcomes in key trials to comparative insights on advanced therapies, with our short summary articles available now #MedSky #EADV2025 #DermSky
ow.ly/P2cf50X0VnN
BAD Recent Highlights from 2025. Read now.
Are you heading home after #EADVCongress?✈️🚂 While you’re traveling, take a look at some recent #dermatology highlights from the BAD journals with their new collection. 📚 oxford.ly/3K9sKWV
That’s it for our round-up of one of the many 'Controversies' sessions at this year’s #EADVCongress. For more insights on AA, visit Medthority now for the updates you need to know #EADV2025 #MedSky #DermSky
ow.ly/nJax50WZh7u
❓Where do you stand on PRP for alopecia areata? Promising frontier or premature hype? Join the conversation in the comments below #EADVCongress #EADV2025 #MedSky #DermSky
The debate reflected a broader tension in dermatology: innovation vs evidence. PRP is biologically plausible and increasingly popular, but is it ready for prime time in AA? #EADVCongress #EADV2025 #MedX #DermSky
Sigall emphasized the importance of standardization: dose, purity, activation, and efficiency of PRP prep all impact outcomes. Without consistency, results can vary widely #EADVCongress #EADV2025 #MedSky #DermSky
Rakowska countered with caution, highlighting:
💵 High costs
❗Procedural risks
📄Lack of support in contemporary guidelines
Plus, she pointed to British guidance favoring established therapies over PRP #EADVCongress #EADV2025 #MedSky #DermSky
Sigall started by arguing in favor of PRP, citing:
🩸Capillary formation
🩸Improved nutrient delivery
🩸Anti-apoptotic effects
These mechanisms may support follicle survival and regrowth in AA #EADVCongress #EADV2025 #MedSky #DermSky
Platelet-rich plasma (PRP) therapy for alopecia areata (AA) remains one of dermatology’s most debated topics. At #EADVCongress, Daniel Asz Sigall and Adriana Rakowska went head-to-head on its merits and limitations. Catch-up on the debate with our thread below #EADV2025 #MedSky #DermSky
Lex is at the #EADVCongress 2025 in Paris! The European Academy of Dermatology and Venereology is the place to be for cutting-edge insights in #dermatology & #venereology. Patient organizations play a vital role—amplifying voices, sharing experiences, and driving change.
If you enjoyed reading through our highlights of the 'Hidradenitis suppurativa' session at #EADVCongress, keep an eye on our #dermatology hub for congress highlights coming soon #EADV2025 #MedSky #DermSky
ow.ly/c8Nv50WYIce
That's a wrap! From phenotypes to pregnancy, comorbidities to combined care — #EADVCongress spotlighted the complexity of HS. Early action, holistic strategies, and patient-centred innovation are shaping the future of HS care #EADV2025 #MedSky #Dermatology #DermSky
What does the future hold for HS management? Emerging therapies like GLP-1 analogues and microbiome modulations show promise in easing the burden of disease in women #EADVCongress #EADV2025 #MedSky #Dermatology #DermSky
🤰With a diagnostic delay of ~7 years and impacts on pregnancy and childbirth, Ganceviciene called for improvements to diagnosis in women and a tailored approach to HS care at #EADVCongress #EADV2025 #MedSky #Dermatology #DermSky
👩How does HS affect women? Ruta Ganceviciene shared how differences in the skin microbiome between men and women may help explain the disparity in HS prevalence #EADVCongress #EADV2025 #MedSky #Dermatology #DermSky
“You have to remove it completely to stop it coming back.” Villani highlighted the critical role of surgical intervention in HS management and advocated for a combined approach: biologics, surgery, and holistic care #EADVCongress #EADV2025 #MedSky #Dermatology #DermSky
🕰️“Early matters.” Alex Villani stressed the importance of early intervention and a holistic approach to modify disease progression in HS. Weight loss, smoking cessation, reduced friction, microbiome care, and stress management can all play a role #EADVCongress #EADV2025 #MedSky #Dermatology
🧠Are there comorbidities beyond the physical associated with HS? Matusiak shared data on elevating rates of mental health disorders in HS and called for mental health support from day one of diagnosis #EADVCongress #EADV2025 #MedSky #Dermatology #DermSky
Weight reduction can improve HS outcomes! Matusiak noted how GLP-1 analogues show potential as an effective treatment option #EADVCongress #EADV2025 #MedSky #Dermatology #DermSky
🚬What are the associated comorbidities with HS shared at #EADVCongress? Lukasz Matusiak highlighted the link between HS, obesity, and smoking – with a bidirectional relationship between HS and obesity #EADV2025 #MedSky #DermSky
The future of treatment lies in how we define the disease: Jemec’s presentation at #EADVCongress reminds us that understanding HS requires data, imagination, and new frameworks #EADV2025 #Dermatology #MedSky #DermSky
🔍“What are we looking for?” Jemec highlighted the importance of identifying biomarkers to better classify and treat HS #EADVCongress #EADV2025 #Dermatology #MedSky #DermSky
💭“We need imagination to see where the problems are.” Jemec called for creative thinking and new perspectives to tackle the challenges of HS at #EADVCongress #EADV2025 #Dermatology #MedSky #DermSky
What were the latest updates on hidradenitis suppurativa (HS) from today’s session at #EADVCongress? From disease forms and comorbidities to disease progression and women’s health, read through our thread below to get closer to the conversations that matter in HS management #MedSky #EADV2025
That’s it for our coverage of CSU sessions at #EADVCongress! If you found this useful, why not explore dermatology resources on Medthority, free and on demand ow.ly/c8Nv50WYIce
A fitting tribute to Marcus Maurer at #EADVCongress today with sessions unpacking CSU and CIU, diagnostic challenges and future therapies — his legacy continues to shape chronic urticaria care #EADV2025 #MedSky #Dermatology #DermSky
Wrapping up the #CSU symposium at #EADVCongress with a lively expert panel Q&A. Discussions ranging from clinical challenges to rare links with cancer as a paraneoplastic sign #EADV2025 #Dermatology #MedSky #DermSky
“We need more drugs” — Ana Giménez-Arnau unpacks CSU endotypes, remission vs relapse, and the evolving landscape of novel therapies for #CSU #EADVCongress #EADV2025 #DermSky #MedSky #Dermatology
